- Home
- WVVI vs HOTH Comparison
WVVI vs HOTH Comparison
Compare WVVI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- HOTH
- Stock Information
- Founded
- WVVI 1983
- HOTH 2017
- Country
- WVVI United States
- HOTH United States
- Employees
- WVVI N/A
- HOTH N/A
- Industry
- WVVI Beverages (Production/Distribution)
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- WVVI Consumer Staples
- HOTH Health Care
- Exchange
- WVVI Nasdaq
- HOTH Nasdaq
- Market Cap
- WVVI 20.4M
- HOTH 18.0M
- IPO Year
- WVVI N/A
- HOTH 2019
- Fundamental
- Price
- WVVI $3.49
- HOTH $1.36
- Analyst Decision
- WVVI
- HOTH Strong Buy
- Analyst Count
- WVVI 0
- HOTH 2
- Target Price
- WVVI N/A
- HOTH $4.50
- AVG Volume (30 Days)
- WVVI 9.2K
- HOTH 989.4K
- Earning Date
- WVVI 11-13-2025
- HOTH 11-11-2025
- Dividend Yield
- WVVI N/A
- HOTH N/A
- EPS Growth
- WVVI N/A
- HOTH N/A
- EPS
- WVVI N/A
- HOTH N/A
- Revenue
- WVVI $38,384,350.00
- HOTH N/A
- Revenue This Year
- WVVI N/A
- HOTH N/A
- Revenue Next Year
- WVVI N/A
- HOTH N/A
- P/E Ratio
- WVVI N/A
- HOTH N/A
- Revenue Growth
- WVVI N/A
- HOTH N/A
- 52 Week Low
- WVVI $3.17
- HOTH $0.66
- 52 Week High
- WVVI $7.18
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- WVVI 41.82
- HOTH 39.43
- Support Level
- WVVI $3.46
- HOTH $1.34
- Resistance Level
- WVVI $3.84
- HOTH $1.52
- Average True Range (ATR)
- WVVI 0.22
- HOTH 0.09
- MACD
- WVVI 0.01
- HOTH -0.01
- Stochastic Oscillator
- WVVI 27.15
- HOTH 25.01
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).